HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS Psychiatric Bulletin Advances in Psychiatric Treatment All RCPsych Journals		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Baptista, T. Articles by Beaulieu, S. Search for Related Content PubMed PubMed Citation Articles by Baptista, T. Articles by Beaulieu, S.

Leptin and antipsychotic drugs

Douglas Hospital Research Center, 6875 Lasalle Blvd, Verdun, Québec, Canada H4H IR3

EDITED BY MATTHEW HOTOPF

Declaration of interest

T.B. is currently a visiting scientist at McGill University, Montreal, and in this capacity is supported by Pfizer Lab, Canada.

There is growing interest in the role of leptin in excessive body weight gain during antipsychotic drug treatment. Herrán et al's (2001) paper is an important contribution to the field. Among other interesting findings they demonstrated that the functioning of the leptin system is preserved during antipsychotic drug administration. However, it is not "the first study analysing the effects of chronic antipsychotic medication on serum leptin levels", since other authors have published relevant data for humans and rats (Baptista et al, 2000; Lacruz et al, 2000; Melkerson et al, 2000).

An important finding by Herrán et al was that olanzapine- and risperidone- treated patients displayed the highest and lowest leptin levels, respectively, "even after controlling for BMI". This may support the contention that olanzapine is promoting a deleterious metabolic profile. That finding also prompts speculation that other mechanisms besides body weight gain could be involved in leptin elevation during antipsychotic treatment.

We have proposed elsewhere that insulin may be one of these additional mechanisms. Insulin is a powerful stimulus for leptin synthesis and secretion. Female rats with sulpiride-induced obesity unexpectedly displayed normal serum leptin (and insulin) levels (Lacruz et al, 2000). In addition, serum leptin and insulin levels correlated positively in healthy people and antipsychotic-treated patients (Baptista et al, 2000, 2001). As olanzapine strongly stimulates appetite, it may promote insulin (and leptin) secretion, with relative independence from body weight gain. Surprisingly, Herrán et al reported that treatment with clozapine (another agent with strong appetite-stimulating properties) was associated with leptin levels similar to those found in haloperidol- and phenothiazine-treated patients (in spite of a higher body weight gain). If it were possible for Herrán et al to furnish the information, readers would benefit from knowing (a) the insulin levels in these patients; (b) a comparison of leptin levels between clozapine-, olanzapine- and risperidone-treated patients and their specific matched controls; and (c) the gender distribution in these treatment groups. If olanzapine- and risperidone-treated subjects display higher and lower leptin levels, respectively, than their controls, and if the gender distribution is similar in the three treatment groups, an additional important contribution will have been brought to the field of psychopharmacology.

REFERENCES

Baptista, T., Lacruz, A., Silvera, R., et al (2000) Body weight gain after administration of antipsychotic drugs: correlation with leptin, insulin and reproductive hormones. Pharmacopsychiatry, 33, 81-88.[Medline]

Baptista, T., Lacruz, A., Angeles, F., et al (2001) Endocrine and metabolic profile in the obesity associated with typical antipsychotic drug-administration. Pharmacopsychiatry, in press.

Herrán, A., García-Unzueta, M. T., Amado, J. A., et al (2001) Effects of long-term treatment with antipsychotics on serum leptin levels. British Journal of Psychiatry, 179, 59-62.[Abstract/Free Full Text]

Lacruz, A., Baptista, T., de Mendoza, S., et al (2000) Antipsychotic drug-induced obesity in rats: correlation between leptin, insulin and body weight during sulpiride treatment. Molecular Psychiatry, 5, 70-76.[Medline]

Melkerson, K. I., Hulting, A. L. & Brismar, K. E. (2000) Elevated levels of insulin, leptin, and blood lipids in olanzapine-treated patients with schizophrenia or related psychoses. Journal of Clinical Psychiatry, 61, 742-749.[Medline]

This Article Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Baptista, T. Articles by Beaulieu, S. Search for Related Content PubMed PubMed Citation Articles by Baptista, T. Articles by Beaulieu, S.